Ventricular tachycardia ablation: a comprehensive review for anesthesiologists

Anesthesia and Analgesia
Alexander J MittnachtAman Mahajan

Abstract

Percutaneous catheter ablation is being increasingly performed in patients with recurrent ventricular tachycardia (VT) unresponsive to medical treatment. Optimal management of patients requires careful consideration of the severity of the underlying cardiac disease, the anesthetic drug interactions, and the procedural technique during VT mapping and ablation. The goal is to choose an anesthetic technique that has the least effect on arrhythmogenicity, allowing reproducibility of the VT in the electrophysiology laboratory. Anesthetics can alter action potential and ventricular depolarization directly through their effects on ion channels and gap junctions, as well as indirectly via their effects on the autonomic nervous system. Furthermore, maintaining hemodynamic stability and monitoring for adequate end-organ perfusion are additional challenges. In this review, we provide a comprehensive update on the currently performed VT ablation procedures and their anesthetic considerations.

References

May 22, 1978·The American Journal of Cardiology·H J WellensJ F Muncharaz
Mar 1, 1979·The American Journal of Cardiology·M E Josephson, L N Horowitz
Jul 1, 1975·The American Journal of Cardiology·B R KliksJ A Abildskov
Jan 1, 1992·Journal of the American College of Cardiology·G N KayV J Plumb
Nov 1, 1989·British Journal of Anaesthesia·I McConachieL Million
Mar 1, 1988·American Heart Journal·V SainiR L Verrier
Nov 1, 1986·American Heart Journal·F C MillerC E Rackley
Dec 1, 1983·Journal of the American College of Cardiology·G O Hartzler
Nov 1, 1980·The Annals of Thoracic Surgery·A H HarkenM E Josephson
Jul 1, 1996·European Journal of Anaesthesiology·D G MichaloudisB J Pollard
May 1, 1997·Journal of the American College of Cardiology·W G StevensonH Khan
May 23, 1998·Acta Anaesthesiologica Scandinavica·E NovalijaZ J Bosnjak
Sep 14, 1999·Journal of the American College of Cardiology·M A WoodL S Liebovitch
Oct 13, 2000·European Journal of Anaesthesiology·E KuenszbergC Hoermann
Mar 17, 2001·Anaesthesia·A KleinsasserF Puehringer
Mar 14, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·C Dean KurthJohn McCann
Jun 11, 2002·Journal of Interventional Cardiology·R T PachulskiH Mirza

❮ Previous
Next ❯

Citations

Jan 21, 2021·International Journal of Environmental Research and Public Health·Nor Amira Syahira Mohd AzmiSrijit Das
Mar 29, 2021·Journal of Cardiothoracic and Vascular Anesthesia·Kara K SiegristAdriana D Oprea

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.